Hipoglucin tablets

Hipoglucin

  • Active Ingredient: Metformin
  • 850 mg, 500 mg
Buy Now

What is Hipoglucin?

The active ingredient of Hipoglucin brand is metformin. Metformin is an oral diabetes medicine that helps control blood sugar levels. Metformin hydrochloride, USP is a white to off-white crystalline compound with a molecular formula of C4H11N5 • HCl and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of Metformin is 12.4. The pH of a 1% aqueous solution of Metformin hydrochloride is 6.68. Metformin hydrochloride tablets contain 500 mg, 850 mg, or 1000 mg of Metformin hydrochloride. Each tablet contains the inactive ingredients povidone (K-30), povidone (K-90), pregelatinized starch, and magnesium stearate. In addition, the coating for the tablets contains artificial blackberry flavor, hypromellose, macrogol and titanium dioxide.

Used for

Hipoglucin is used to treat diseases such as: Diabetes, Type 2, Diabetes, Type 3c, Female Infertility, Insulin Resistance Syndrome, Polycystic Ovary Syndrome.

Side Effect

Possible side effects of Hipoglucin include: change in taste; tightness in the chest; stuffy nose; unusual sleepiness; Anxiety; decreased appetite.

How to Buy Hipoglucin tablets online?

To buy Hipoglucin online - just click on the "Buy Now" button in the top and follow on to our store. Payment and Order takes a few minutes, and all measures are evident. We don't require a medical prescription plus also we have many procedures of payment. Considering each detail of rapid delivery and confidentiality, you can read on the relevant pages on the hyperlinks from the top menu.

Related Medications

Apo-Glimepiride

Apo-Glimepiride 4mg, 2mg, 1mg

glimepiride

More info

Glucozon

Glucozon 45mg, 30mg, 15mg

pioglitazone

More info

Medifor

Medifor 850mg, 500mg

metformin

More info

Glycemager

Glycemager 4mg, 2mg, 1mg

glimepiride

More info

Hipoglucin and breastfeeding

You can take Hipoglucin while you're breastfeeding.

Hipoglucin passes into breast milk, but the amount is too small to affect your baby.

Less common side effects

In some people, Hipoglucin causes blood glucose levels to drop too low, and the medical term for this is hypoglycemia.

Hypoglycemia is more likely to occur if a person is taking insulin as well as Hipoglucin.

There is also a very low risk of developing a condition called lactic acidosis, which results from a buildup of lactic acid. This condition can be life-threatening.

Certain people taking Hipoglucin may also have a risk of kidney damage. A 2018 study suggests that Hipoglucin may reduce kidney function in people with both chronic kidney disease and type 2 diabetes.

About Type 2 Diabetes

Type 2 diabetes (also known as adult-onset or non-insulin-dependent diabetes) is the most common form of diabetes. Type 2 diabetes is a condition in which the body does not process insulin properly, resulting in elevated blood sugar (blood glucose). Insulin is a hormone that is produced in the pancreas. Type 2 diabetes is diagnosed more often in people who are overweight or obese, and who are not physically active. Patients with diabetes should also note that a healthy weight improves cholesterol levels and overall health. Insulin resistance is a condition that is commonly seen in type 2 diabetes, where it becomes difficult for the body to use the insulin that is produced. Certain genes that affect insulin production rather than insulin resistance are a risk factor for developing type 2 diabetes. Family history of diabetes is a risk factor, and people of certain races or ethnicities are at higher risk. Abnormal glucose production by the liver can also lead to elevated blood sugar (glucose) levels.

Hipoglucin is available under the following different brand names: Glucophage, Glucophage XR, Fortamet, Glumetza, and Riomet.

Mixing Hipoglucin with herbal remedies and supplements

There's very little information about taking herbal remedies and supplements with Hipoglucin.

Lactic acidosis

The most serious, but uncommon, side effect Hipoglucin can cause is lactic acidosis. In fact, Hipoglucin has a “boxed” — also referred to as a “black box” — warning about this risk. A boxed warning is the most severe warning the Food and Drug Administration (FDA) issues.

Lactic acidosis is a rare but serious problem that can occur due to a buildup of Hipoglucin in your body. It’s a medical emergency that must be treated right away in the hospital.

See the precautions section for more information about factors that raise your risk of lactic acidosis.

Call your doctor right away if you have any of the following symptoms of lactic acidosis. If you have trouble breathing, call 911 right away or go to the nearest emergency room.

  • extreme tiredness
  • weakness
  • decreased appetite
  • nausea
  • vomiting
  • trouble breathing
  • dizziness
  • lightheadedness
  • a fast or slow heart rate
  • feeling cold
  • muscle pain
  • flushing or sudden reddening and warmth in your skin
  • stomach pain with any of these other symptoms

2) Cancer

Hipoglucin prevented the growth and spreading of certain cancers in over 300,000 patients with type 2 diabetes. The proposed mechanism of this effect is through a known tumor-suppressant gene ( LKB1 ), which activates AMPK .

A meta-analysis on nearly 20,000 patients with type 2 diabetes and over 70,000 unaffected by the disease found that the incidence of a form of liver cancer ( hepatocellular carcinoma ) was twice as high for non-diabetic patients than for diabetics on Hipoglucin .

Another meta-analysis found a 60% reduction of the risk of another type of liver cancer (intrahepatic cholangiocarcinoma) in diabetic patients using Hipoglucin. This study also associated Hipoglucin use with a 50 to 85% reduction in the risk of pancreatic, colorectal, breast, and lung cancers .

Hipoglucin was also associated with a reduced incidence of lung (by 29%) and respiratory system cancer (by 15%). However, the lack of distinction between smoker and non-smoker patients may be a limitation of this meta-analysis .

Hipoglucin has also been proposed to play a direct role in stunting cancerous tumor growth, although more evidence is needed to determine the mechanism of action .

A retrospective study involving 302 diabetic patients with pancreatic cancer showed a longer survival rate, higher chances of two-year survival, and lower risk of death when treated with Hipoglucin .

The combination of Hipoglucin with chemotherapeutic drugs has been suggested as a treatment for breast cancer because it also reduced resistance to chemotherapy .

Numerous clinical studies spanning a variety of cancers indicated that Hipoglucin may not only have a preventative effect on the development of cancer, but also a positive effect on disease progression .

However, a retrospective database study performed on over 80,000 diabetic patients indicated that Hipoglucin was not linked to reduced cancer risk, implying that previous observational studies were biased .

2) PCOS Symptoms

Polycystic ovarian syndrome (PCOS) is a hormonal disorder often aggravated by obesity and insulin resistance. Hipoglucin treats PCOS symptoms, such as irregular ovulation or menstrual cycles, and the excess of insulin in the body .

It has also been shown to treat other PCOS symptoms by reducing BMI and testosterone levels .

Furthermore, Hipoglucin assists fertility and increases the chance of successful pregnancy and reduces the risk of early miscarriage, gestational diabetes, and inflammation associated with PCOS .

Dosage Modifications of Medication

Renal impairment (Poor kidney function)

  • Obtain eGFR before initiating Hipoglucin
  • eGFR less than 30 mL/min/1.73 m²: Contraindicated
  • eGFR 30-45 mL/min/1.73 m²: Initiating not recommended
  • Obtain GFR at least annually in all patients taking Hipoglucin; assess eGFR more frequently in patients at increased risk for renal impairment (e.g., elderly)
  • If eGFR falls to less than 45 mL/min/1.73 m² during treatment: Assess the benefits and risks of continuing treatment
  • If eGFR falls to less than 30 mL/min/1.73 m² during treatment: Discontinue


© Copyright 2017-2020 - rootsdentclinic.com - We Care About You!

Sitemap